Member Info for inanaco

please attend a specsaver session so that you can read back what you have written ...

so you could have spectacles rather than creating a spectacle

Thanks Mr Pfizer

""" I have attempted to value the pipeline from a commercial perspective."""

Dear Ruck (pfizer) ....

please attempt a takeover ...

It will help the SP

Thanks

Lindy is not a legal entity ..

Because the Director is also the Chief Scientific officer .. Lindy ...

It would be so dangerous to make a bid ... and what do you think would happen to the share price as this aggressive bidder start acquiring shares ??? sits at 5p while idiots sell to "it"

A hostile takeover is the acquisition of one company (called the target company) by another (called the acquirer) that is accomplished by going directly to the company's shareholders or fighting to replace management to get the acquisition approved

what a load of garbage ... """""" if you sell at 50p 60p 70p """"""

you would be selling to new shareholders who are blue sky thinkers ..

"""" I have attempted to value the pipeline from a commercial perspective."""

really are you buying it ???

the standard of posts on here is becoming a joke no wonder its a lonely place

protein shapes and the interactions thereof?

like mathematical steaks or fish ? as that is the only protein i need

like playing with plasticine .. gave that up in my early education

its not a vaccine like ours TF .. I suspect its using cytokines to attract T cells into the environment .. it's the radiation that shatters the cancer to allow fragmentation and """possible"""" recognition by the dendritic cells

Immunobody primes Professional Antigen presenting cells (dendritic) cells direct and activates t cells by cross presentation

it does not matter that you use quantum maths to buy or sell a share ...

why do i need it ? explain

you can question why ? .. but to do that you would have to argue against the science ...

how the stock market values it ... well in 2012 it was £100m mcap... so it does fluctuate ... which date and price are you suggesting the market was correct ?

who is "they" ... out of space people ?

if you had asked .. do I think I am capable of reading and absorbing (learning) the subjects in hand ... then i would say yes, as i have had 7 years of trying to get my head round it ... the question then arises ... in all of my posts do you question the validity of my response ?

well how could you ? you don't have sufficient scientific thinking which you just told me

seems it's you that has the issue .. not me

don't worry you are not alone, the amount of people that argue and then post "i failed o level Biology" are numerous

are you sufficiently scientific to ask ?

CD4 T cells can differentiate into multiple effector subsets, including ThCTL that mediate MHC class II–restricted cytotoxicity.

that is a CD4+t Cell slewed to TH1 with cytotoxicity .... all Lindy has done is Programmed it ........

Citrullinated cancers cells when stressed with Interferon gamma express a MHC 11 class epitope

Moditope .....

two words

"eradication" and "complete response rates"

it has nothing to do with "if they want us"

it has more to do with "if we want them"

that is the beauty of a land grab patent ... we the shareholders own it ...

did you understand the science what i posted early ? because that is what you should be posting on ..

the fact that Cd4 going cytotoxic is rare difficult to track but is non toxic its natural

Ray what does this mean ... """ high crowd "" is that a metaphor .... drugs ? or

I have not threatened u ?

i was describing the post as Stones and mine as granite slabs ..

and i was happy with your posts ... because you have a Bazooka buy coming possibly influenced by my simplification of Lind's science

do you agree you still hold ?

the issue is ,,,,,,,,, knowlesi .. you have no response .. ?

you throw stones while i drop 20 ton granite slabs on you ..

we are months away from knowing the effects of moditope TCR .. if BioNtech take them on .. do you actually understand what that means ????

BioNtech has confirmed Scancells Data ....

That is japan Covered ... 2033

Japanese patent number 6,490,581, entitled Anti-tumour Response to Modified Self-epitopes, covers using any citrullinated tumour-associated T cell epitope to treat patients with cancer. It has a nominal expiry date of August 2033. This grant in Japan follows the grant of patents in the US, Europe, South Africa and Australia, and acceptance for grant in China. Counterparts to these patents continue to be prosecuted in other territories of importance to Scancell in order to further expand Scancell's IP portfolio.

Keep Kidding yourself Knowlesi ..

mentioned this before ........

The phenotype of NKG2C/E+ ThCTL indicates they are highly activated effectors expressing high levels of binding to P-selectin, T-bet, and Blimp-1, and that more of them secrete IFN-?

IFN - ? = interferon gamma

just so that you understand ..........

IFN? is an important activator of macrophages and inducer of Class II major histocompatibility complex (MHC) molecule expression.

so that cytokine releases MORE MODITOPE expression ......... this is why you will get Clonal Expansion

this is why Lindy describes it as "destruction" of the cancer ....

this is why the Mouse will not die ...

if it translates into Humans its mind blowing value ........